Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2][9]. Core Insights - The increase in Indonesia's crude palm oil export levy from 10% to 12.5% is expected to enhance the profitability per ton for the company's operations in Indonesia [3][4]. - The company is positioned as a leading enterprise in domestic oil chemical, surfactants, and personal care processing, with significant production capacities exceeding 1 million tons per year for oil chemical products and over 1.2 million tons for surfactants [3][9]. - The company anticipates revenue growth of 39% in 2025, followed by 16% in 2026 and 8% in 2027, with net profit projections of 3.0 billion, 4.1 billion, and 5.1 billion yuan respectively during the same period [3][9]. Summary by Relevant Sections Tax Rate Impact - The increase in the export levy is expected to boost the absolute tax amount paid, thereby enhancing the profitability of the company's Indonesian subsidiary, Dukuda [4][6]. Production Capacity and Profitability - Dukuda's new production capacity is being released in an orderly manner, and the combination of increased tax revenue and production capacity is expected to lead to simultaneous volume and price increases, enhancing overall profitability [6][9]. - The utilization rates for surfactants and OEM/ODM processing are steadily improving, which is anticipated to drive profitability upward [7]. Future Growth Potential - The company is focusing on the gradual ramp-up of OPO structured fat production, which is projected to achieve sales in the kiloton range within the year [8]. - The company has secured contracts with major clients such as White Cat and Unilever, which will help improve the operational rates of its processing capacity [7].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2][9]. Core Views - The increase in Indonesia's crude palm oil export levy from 10% to 12.5% is expected to enhance the profitability per ton for the company's Dukuda operations in Indonesia [3][4]. - The Dukuda project is progressing steadily, with new capacity expected to be released in an orderly manner, which, combined with the increased tax, is anticipated to achieve both volume and price growth [3][6]. - The utilization rates for surfactants and OEM/ODM processing are continuously improving, which is expected to drive profitability upward [3][7]. - The company is poised to gradually ramp up its OPO structured fat production, with expectations of achieving significant sales within the year [3][8]. Financial Projections - The company is projected to generate revenues of 14.9 billion, 17.3 billion, and 18.8 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 39%, 16%, and 8% [3][9]. - The net profit attributable to the parent company is expected to be 300 million, 410 million, and 510 million yuan for the same years, reflecting year-on-year growth rates of 119%, 37%, and 24% [3][9]. - The diluted EPS is forecasted to be 0.63, 0.87, and 1.08 yuan, with corresponding P/E ratios of 19.6, 14.2, and 11.4 times [3][9].